Berberine improves insulin sensitivity and glucose tolerance, reduces albuminuria, and activates AMPK and PGC-1α pathways. These regulate mitochondrial energy homeostasis, fatty acid oxidation, and protect podocytes from oxidative stress in diabetic kidney disease. The gene discussed is PPARGC1A; the disease is diabetic kidney disease.